Yahoo Web Search

    • Drug Duo Targeting ATR Enzyme Shrinks SCLC Tumors

      Medscape· 16 hours ago

      Combining an ataxia telangiectasia and rad3-related (ATR) inhibitor with topoisomerase 1 (TOP1) yielded an objective response in more than a third of patients with small-cell